SCHEMBL15418062

SCHEMBL15418062

CCCCCC(=O)C(Cc1ccc(-c2ccccc2C#N)nc1)C(=O)OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.36
FAAH O00519 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 1/20 0.34
MME P08473 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
S1PR1 P21453 2/20 0.34
BRS3 P32247 2/20 0.34
PPARG P37231 1/20 0.34
PPARD Q03181 1/20 0.34
PPARA Q07869 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
FFAR1 O14842 1/20 0.34
AKR1B1 P15121 1/20 0.34
ECE1 P42892 1/20 0.34
AGTR1 P30556 1/20 0.34
AGTR2 P50052 1/20 0.34
PTPN1 P18031 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1370921 0.97 TSHR (0.39) TSHRFAAHSMN1; SMN2MMEALDH1A1
SCHEMBL16457755 0.93 PRKDC (0.37) TSHRFAAHMMEALDH1A1S1PR1
SCHEMBL15418005 0.90 FAAH (0.40) TSHRFAAHSMN1; SMN2MMEALDH1A1
SCHEMBL16458596 0.89 PPARG (0.36) TSHRSMN1; SMN2MAPTMMEALDH1A1
SCHEMBL11897519 0.87 TSHR (0.40) TSHRFAAHSMN1; SMN2MMES1PR1
SCHEMBL1374077 0.85 MAPT (0.39) SMN1; SMN2MAPTALDH1A1BRS3L3MBTL1
SCHEMBL1371403 0.85 MME (0.48) TSHRMMEALDH1A1CYP3A4CYP2C9
SCHEMBL15418090 0.83 PRKDC (0.39) TSHRFAAHSMN1; SMN2MMES1PR1
SCHEMBL633444 0.82 MME (0.48) TSHRMMEPPARGFFAR1AKR1B1
SCHEMBL27948271 0.81 ANPEP (0.36) TSHRSMN1; SMN2MAPTBRS3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315493-B2 Phenylpyridine derivative and drug containing same KOWA COMPANY, LTD. (JP) 2016-04-19 US disclosed
EP-2687523-B1 NOVEL PHENYLPYRIDINE DERIVATIVE AND DRUG CONTAINING SAME KOWA CO (JP) 2016-01-06 EP disclosed
CN-103459380-B Phenylpyridine derivative and medicine containing the same KOWA CO 2015-07-15 CN disclosed
EP-2687523-A1 NOVEL PHENYLPYRIDINE DERIVATIVE AND DRUG CONTAINING SAME Kowa Company Ltd. (JP) 2014-01-22 EP disclosed
US-20140011823-A1 NOVEL PHENYLPYRIDINE DERIVATIVE AND DRUG CONTAINING SAME KOWA COMPANY, LTD. (JP) 2014-01-09 US disclosed
CN-103459380-A Novel phenylpyridine derivative and medicine containing the same KOWA CO 2013-12-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140011823-A1 NOVEL PHENYLPYRIDINE DERIVATIVE AND DRUG CONTAINING SAME AGTR2, AGTR1, PPARD TSHR 289/4885FAAH 2489/4885SMN1; SMN2 4689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.